Engineers Gate Manager LP Bristol Myers Squibb CO Transaction History

Engineers Gate Manager LP

  • $5.55 Billion
  • Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Engineers Gate Manager LP holds 162,635 shares of BMY stock, worth $7.47 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
162,635
Previous 221,791 26.67%
Holding current value
$7.47 Million
Previous $12.5 Million 20.93%
% of portfolio
0.18%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$53.9 - $63.11 $3.19 Million - $3.73 Million
-59,156 Reduced 26.67%
162,635 $9.92 Million
Q4 2024

Feb 14, 2025
SELL
$51.92 - $59.94 $18 Million - $20.8 Million
-347,325 Reduced 61.03%
221,791 $12.5 Million
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $199,013 - $259,681
-5,018 Reduced 0.87%
569,116 $29.5 Million
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $22.8 Million - $30 Million
565,788 Added 6779.15%
574,134 $23.8 Million
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $2.14 Million - $2.43 Million
-44,623 Reduced 84.24%
8,346 $452,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $2.94 Million - $3.51 Million
-60,723 Reduced 53.41%
52,969 $2.72 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $4.88 Million - $5.46 Million
84,348 Added 287.45%
113,692 $6.6 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $371,301 - $412,272
5,828 Added 24.78%
29,344 $1.88 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $1.59 Million - $1.8 Million
-24,135 Reduced 50.65%
23,516 $1.63 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $2.88 Million - $3.41 Million
42,077 Added 754.88%
47,651 $3.43 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $178 - $105,424
1,372 Added 32.65%
5,574 $396,000
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $305,149 - $336,075
4,202 New
4,202 $324,000
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $1.67 Million - $2 Million
-27,101 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $5.3 Million - $6.17 Million
-98,738 Reduced 78.46%
27,101 $1.69 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $5.62 Million - $6.58 Million
94,902 Added 306.76%
125,839 $7.45 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $2.46 Million - $2.68 Million
-39,797 Reduced 56.26%
30,937 $2.07 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $301,743 - $339,372
-5,085 Reduced 6.71%
70,734 $4.47 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $3.49 Million - $3.96 Million
60,447 Added 393.23%
75,819 $4.7 Million
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $4.98 Million - $5.52 Million
-86,660 Reduced 84.93%
15,372 $927,000
Q2 2020

Aug 17, 2020
BUY
$54.82 - $64.09 $4.62 Million - $5.4 Million
84,249 Added 473.76%
102,032 $6 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $1.99 Million - $2.89 Million
-42,910 Reduced 70.7%
17,783 $991,000
Q4 2019

Feb 14, 2020
SELL
$49.21 - $64.19 $1.06 Million - $1.39 Million
-21,597 Reduced 26.24%
60,693 $3.9 Million
Q3 2019

Nov 14, 2019
SELL
$42.77 - $50.71 $3.76 Million - $4.46 Million
-87,936 Reduced 51.66%
82,290 $4.17 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $7.6 Million - $8.4 Million
170,226 New
170,226 $7.72 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $631,637 - $819,081
-12,954 Closed
0 $0
Q3 2018

Nov 01, 2018
BUY
$55.19 - $62.25 $714,931 - $806,386
12,954 New
12,954 $804,000
Q2 2018

Aug 03, 2018
SELL
$50.53 - $62.98 $3.87 Million - $4.83 Million
-76,634 Closed
0 $0
Q1 2018

May 07, 2018
BUY
$59.92 - $68.98 $1.46 Million - $1.68 Million
24,307 Added 46.45%
76,634 $4.85 Million
Q4 2017

Feb 01, 2018
BUY
$59.94 - $65.35 $825,613 - $900,130
13,774 Added 35.73%
52,327 $3.21 Million
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $2.13 Million - $2.46 Million
38,553
38,553 $2.46 Million

Others Institutions Holding BMY

# of Institutions
2,677
Shares Held
1.58B
Call Options Held
25.9M
Put Options Held
24.1M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $97.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email